Balaji Amines Reports Q2 Revenue of ₹4.68 Billion Versus ₹3.4 Billion YoY

Market snapshot: Balaji Amines Limited reported its Q2 financial results, delivering top-line revenue from operations of ₹468 crore compared to ₹340 crore in the corresponding period of the previous fiscal year. This represents a year-on-year revenue growth of approximately 37.65%, signaling operational stabilization in specialty chemicals.

Data Snapshot

• Q2 revenue from operations reached ₹468 crore, up from ₹340 crore in the year-ago quarter.
• Year-on-year revenue growth stands at approximately 37.65% for the quarter.
• Commercial production at the Unit-III Solapur Acetonitrile plant commenced in September 2026 with an enhanced capacity of 1,440 tonnes per month.

What's Changed

• Top-line revenue expanded to ₹468 crore in Q2, up from ₹340 crore in the prior-year period.
• Derived YoY revenue growth stands at approximately 37.65% (derived: ₹468 crore vs ₹340 crore).

Key Takeaways

• Top-line expansion: Q2 revenue reached ₹468 crore, showing momentum compared to ₹340 crore YoY.
• YoY Growth: Revenue increased by approximately 37.65% over the corresponding quarter of the previous fiscal year.
• Capacity reinforcement: Upgraded Acetonitrile (ACN) production facility at Solapur (1,440 TPM) supports higher product throughput.

SAHI Perspective

The 37.65% YoY growth in revenue to ₹468 crore indicates top-line stabilization for Balaji Amines after extended global destocking cycles in specialty chemical supply chains. Commercial operations at expanded capacity facilities positions the firm to capture demand across pharmaceutical and agrochemical client bases.

Market Implications

The top-line rebound signals improving off-take and volume stability in aliphatic amines and derivative products. Investors will watch operational margins and raw material trends, particularly in methanol and ammonia, to gauge margin sustainability.

Trading Signals

Market Bias: Bullish

Strong Q2 revenue expansion to ₹468 crore from ₹340 crore YoY reflects solid top-line recovery and operational stabilization in the specialty chemicals sector.

Overweight: Specialty Chemicals, Agrochemical Intermediates

Trigger Factors:

• Sustained operating profit margins in detailed financial filings
• Capacity utilization levels at the upgraded Solapur Acetonitrile unit
• Input raw material price movements for methanol and ammonia

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian specialty chemical sector has experienced pricing pressures and extended customer destocking over past cycles. Balaji Amines' revenue rebound to ₹468 crore reflects early indicators of volume demand recovery in core aliphatic amines and derivative product lines.

Key Risks to Watch

• Cost volatility in principal raw material inputs including methanol and ammonia.
• Import competition and pricing dynamics in core aliphatic amine categories.
• Demand fluctuations across downstream active pharmaceutical ingredient (API) markets.

Recent Developments

In September 2026, Balaji Amines commenced commercial production at its upgraded Acetonitrile (ACN) plant at Unit-III in Solapur, expanding total installed capacity to 1,440 tonnes per month.

Closing Insight

Balaji Amines' 37.65% YoY revenue rebound to ₹468 crore reflects improving commercial off-take, reinforced by strategic capacity expansion in specialty chemical intermediates.

High Performance Trading with SAHI.